aurobindo pharma share price: Aurobindo Pharma shares jump 6% on reports of nod to launch cancer drug Revlimid

On Wednesday, Aurobindo Pharma's wholly owned subsidiary Auro Vaccines Private Limited informed about entering into a License Agreement with Hilleman Laboratories Singapore Pte. to develop, manufacture and commercialise a pentavalent vaccine candidate used in children vaccination.

Related Keywords

Hyderabad ,Andhra Pradesh ,India ,Aurobindo Pharma ,Auro Vaccines Private ,Zee Business ,Auro Vaccines Private Limited ,License Agreement ,Hilleman Laboratories Singapore ,Auro Vaccines ,Simple Moving Averages ,Aurobindo Pharma Share Price ,Vaccine ,Cancer Drug ,Volatility ,Growth ,